DOI QR코드

DOI QR Code

The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy

  • Published : 2013.05.01

Abstract

Keywords

References

  1. Sun HK, Lee YM, Han KH, Kim HS, Ahn SH, Han SY. Phosphodieste rase inhibitor improves renal tubulointerstitial hypoxia of the diabetic rat kidney. Korean J Intern Med 2012;27:163-170. https://doi.org/10.3904/kjim.2012.27.2.163
  2. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52.
  3. Teixeira MM, Gristwood RW, Cooper N, Hellewell PG. Phosphodiesterase (PDE)4 inhibitors: anti-inf lammatory drugs of the future? Trends Pharmacol Sci 1997;18:164-171. https://doi.org/10.1016/S0165-6147(97)90613-1
  4. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003;289:3273-3277. https://doi.org/10.1001/jama.289.24.3273
  5. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006;55:1832-1839. https://doi.org/10.2337/db05-1620
  6. MacIsaac RJ, Panagiotopoulos S, McNeil KJ, et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care 2006;29:1560-1566.2009;31:848-854.